Cohance Lifesciences mutual fund holdings
NSE: COHANCEBSE: 543064Pharmaceuticals & BiotechnologySmall Cap
Cohance Lifesciences Limited · Formerly Suven Pharmaceuticals · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2020
Last close ₹476.05down ₹3.20 (0.67%)BSE ₹476.80
Share price at the NSE close on 28 Oct 2026. Previous close ₹479.25.
28 Oct: open ₹484.00, high ₹487.40, low ₹471.70
52-week range of traded prices to 28 Oct 2026
₹266.70Low, 9 Mar 2026₹870.75High, 28 Oct 2025
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18,214 Cr428th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 171.45
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹21 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 142.74
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.66
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹21 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 4.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,27,12243.3% delivered
106 mutual funds from 24 fund houses held Cohance Lifesciences at the end of Sep 2026, each fund counted once across its plans: ₹2,826 Cr between them Value held by mutual funds. The market value of every mutual fund's holding of the company at the month's end, added up, as each fund reports it. Value held by mutual funds in the glossary, 16.64% Mutual funds' share of the company. The shares every mutual fund holds at the month's end, added up and divided by the company's shares in issue. Read from the funds' own portfolios, so it can differ from the mutual funds line of the company's quarterly shareholding filing. Mutual funds' share of the company in the glossary of the company's shares.
Mutual funds holding Cohance Lifesciences, Sep 2026
Largest holding first.
How many funds hold the company each month, and what their holdings are worth, from each month's portfolio disclosures
- Funds holding it
- Value held, ₹ crore
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Buying and selling, month by month
How many funds bought for the first time, bought again, added, cut or sold out, against their own previous month.
Funds, by what they did
Largest first-time buy in Sep 2026: SBI Balanced Hybrid Fund; largest buy by a fund that held it before: UTI Value Fund; largest addition: UTI Healthcare Fund.Largest cut in Sep 2026: ICICI Prudential Innovation Fund; largest exit: ICICI Prudential Value Fund.
Shares held by all funds
- Shares heldShares held by all funds. The shares every mutual fund holding the company reports at the month's end, added up. Shares held by all funds in the glossary
Fund by fund, month by month
| Fund | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 ICICI Prudential Healthcare FundICICI Prudential Mutual Fund | 17,81,254+6,17,169 (+53.0%) | 30,68,016+12,86,762 (+72.2%) | 36,72,095+6,04,079 (+19.7%) | 48,89,358+12,17,263 (+33.2%) | 60,81,373+11,92,015 (+24.4%) | 66,29,758+5,48,385 (+9.0%) | 61,21,393−5,08,365 (−7.7%) | 65,38,941+4,17,548 (+6.8%) | 62,66,199−2,72,742 (−4.2%) | 62,66,692+493 (0.0%) | 62,66,692 | 62,66,692 |
 SBI Multi Asset Allocation FundSBI Mutual Fund | – | – | – | – | – | 10,43,487Bought | 20,00,000+9,56,513 (+91.7%) | 52,00,000+32,00,000 (+160.0%) | 52,00,000 | 52,00,000 | 52,00,000 | 52,00,000 |
 Invesco India Contra FundInvesco Mutual Fund | 33,23,946 | 35,98,511+2,74,565 (+8.3%) | 35,98,511 | 35,98,511 | 35,98,511 | 35,98,511 | 40,13,973+4,15,462 (+11.6%) | 40,13,973 | 40,13,973 | 40,13,973 | 43,93,667+3,79,694 (+9.5%) | 43,93,667 |
 HDFC Balanced Advantage FundHDFC Mutual Fund | 25,00,285+8,77,504 (+54.1%) | 33,53,052+8,52,767 (+34.1%) | 41,43,548+7,90,496 (+23.6%) | 41,43,548 | 41,43,548 | 41,43,548 | 41,43,548 | 41,43,548 | 41,43,548 | 41,43,548 | 41,43,548 | 41,43,548 |
 DSP Healthcare FundDSP Mutual Fund | 29,67,600+2,03,515 (+7.4%) | 29,67,600 | 29,67,600 | 29,72,213+4,613 (+0.2%) | 29,72,213 | 29,72,213 | 31,40,630+1,68,417 (+5.7%) | 31,79,881+39,251 (+1.3%) | 31,79,881 | 32,02,999+23,118 (+0.7%) | 32,02,999 | 32,02,999 |
 Bandhan Small Cap FundBandhan Mutual Fund | 4,19,345+1,65,000 (+64.9%) | 10,54,345+6,35,000 (+151.4%) | 16,45,809+5,91,464 (+56.1%) | 21,60,139+5,14,330 (+31.3%) | 23,07,139+1,47,000 (+6.8%) | 23,07,139 | 23,31,139+24,000 (+1.0%) | 26,78,528+3,47,389 (+14.9%) | 27,25,813+47,285 (+1.8%) | 30,97,757+3,71,944 (+13.7%) | 30,97,757 | 31,27,757+30,000 (+1.0%) |
| SBI Balanced Advantage FundSBI Mutual Fund | – | – | – | – | – | – | – | 2,50,920Bought | 30,00,000+27,49,080 (+1,095.6%) | 30,00,000 | 30,00,000 | 30,00,000 |
| DSP Aggressive Hybrid FundDSP Mutual Fund | 16,41,445+57,266 (+3.6%) | 17,30,282+88,837 (+5.4%) | 20,75,725+3,45,443 (+20.0%) | 28,08,197+7,32,472 (+35.3%) | 28,08,197 | 28,08,197 | 28,08,197 | 28,08,197 | 28,08,197 | 28,08,197 | 23,47,265−4,60,932 (−16.4%) | 23,47,265 |
| SBI Healthcare Opportunities FundSBI Mutual Fund | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 12,00,000 | 10,00,000−2,00,000 (−16.7%) | 18,00,000+8,00,000 (+80.0%) | 22,00,000+4,00,000 (+22.2%) | 22,00,000 | 22,00,000 | 22,00,000 |
| SBI MNC FundSBI Mutual Fund | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 10,00,000 | 8,00,000−2,00,000 (−20.0%) | 18,00,000+10,00,000 (+125.0%) | 22,00,000+4,00,000 (+22.2%) | 22,00,000 | 22,00,000 | 22,00,000 |
| ICICI Prudential Aggressive Hybrid FundICICI Prudential Mutual Fund | 5,50,000Bought | 9,51,137+4,01,137 (+72.9%) | 9,51,137 | 9,51,137 | 9,51,137 | 13,64,608+4,13,471 (+43.5%) | 22,64,664+9,00,056 (+66.0%) | 22,64,664 | 22,64,664 | 22,14,332−50,332 (−2.2%) | 21,65,254−49,078 (−2.2%) | 21,65,254 |
| DSP Large & Mid Cap FundDSP Mutual Fund | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 27,62,648 | 20,58,490−7,04,158 (−25.5%) | 20,58,490 |
| DSP Flexi Cap FundDSP Mutual Fund | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 24,53,891 | 19,73,403−4,80,488 (−19.6%) | 19,73,403 |
| ICICI Prudential India Opportunities FundICICI Prudential Mutual Fund | – | 6,28,300Bought | 9,50,116+3,21,816 (+51.2%) | 9,88,371+38,255 (+4.0%) | 23,11,979+13,23,608 (+133.9%) | 30,36,603+7,24,624 (+31.3%) | 23,77,398−6,59,205 (−21.7%) | 23,77,398 | 23,77,398 | 23,77,398 | 18,54,082−5,23,316 (−22.0%) | 18,54,082 |
| Invesco India Focused FundInvesco Mutual Fund | 13,88,970 | 13,88,970 | 13,88,970 | 13,88,970 | 13,88,970 | 13,88,970 | 17,63,647+3,74,677 (+27.0%) | 17,63,647 | 17,63,647 | 17,63,647 | 17,63,647 | 17,63,647 |
Shares held at each month end. Under them, the change on the fund's previous month; a fund that files only weights shows the word. “After a gap” is a fund holding it after a month with no portfolio on record, so when it bought is not known; “Not filed” is one gone across such a gap.